文献速递前列腺癌

快速1.5-T双参数MRI与3.0-T多参数MRI在前列腺癌风险男性分诊中的前瞻性比较

Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
PubMed 文献 · BJU Int · 2018-10-19

结果显示fMRI诊断准确性优异,基于病灶的AUC为0.961,基于患者的AUC为0.975,PI-RADS评分一致性良好(κ=0.78)。结论提示fMRI可安全替代传统mpMRI进行分诊,节省时间和对比剂注射。

要点

  • 快速1.5-T双参数MRI诊断前列腺癌的AUC达0.961(病灶分析)和0.975(患者分析)。
  • 两种方案PI-RADS评分一致性良好(κ=0.78),fMRI仅漏诊3例PI-RADS 4病灶。
  • fMRI(<15分钟)可安全替代ESUR 3.0-T mpMRI分诊,节省时间和对比剂。

核心结论

  • 在高危前列腺癌男性分诊中,快速1.5-T双参数MRI(T2WI+DWI,<15分钟)可安全替代传统ESUR 3.0-T多参数MRI协议,节省时间和对比剂注射。

研究设计与样本

  • mpMRI上PI-RADS v.2评分≥3/5的患者接受MRI/超声融合引导前列腺穿刺活检。
  • 以mpMRI为参考,采用ROC曲线分析评估fMRI性能,用Cohen's κ计算PI-RADS v.2评分的一致性。

主要发现

  • 基于病灶分析:fMRI的AUC为0.961(P<0.001),敏感度95%,特异度97%,PPV 99%,NPV 89%。
  • 基于患者分析:fMRI的AUC为0.975(P<0.001),敏感度98%,特异度97%,PPV 98%,NPV 97%。
  • 两种协议PI-RADS评分一致性良好(κ=0.78 [0.57; 0.99]);fMRI漏诊3例PI-RADS 4病灶。
  • 漏诊病灶活检结果:2例无癌(每结节两针),1例Gleason 6癌;仅1例fMRI假阳性(PI-RADS 4),活检阴性。

临床怎么用

  • 对于前列腺癌风险≥10%的男性,可采用快速1.5-T双参数MRI(T2WI+DWI)作为分诊检查,替代传统3.0-T多参数MRI。
  • fMRI节省检查时间(<15分钟)并避免对比剂注射,且诊断性能与mpMRI高度一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare prospectively the diagnostic performance of a biparametric (T2-weighted imaging [T2WI] and diffusion-weighted imaging [DWI]) 1.5-T fast magnetic resonance imaging (fMRI) protocol with the standard 3.0-T multiparametric MRI (mpMRI) protocol of the European Society of Urological Imaging (ESUR) in men referred for a prostate biopsy. PATIENTS AND METHODS: Ninety patients with a prostate cancer (PCa) risk of ≥10% according to the SWOP calculator 4 underwent first fMRI and then the reference mpMRI. Patients with Prostate Imaging Reporting and Data System (PI-RADS) v.2 lesions ≥3/5 on the mpMRI were scheduled for MRI/ultrasonography (US) fusion-guided prostate biopsy. Performance of fMRI was assessed using receiver-operating characteristic curve analysis and mpMRI as reference. Calculation of inter-technique agreement on PI-RADS v.2 score by Cohen's κ. RESULTS: The diagnostic accuracy of fMRI shown by the lesion-based analysis was excellent: area under the curve (AUC) 0.961 (P < 0.001), sensitivity 95%, specificity 97%, positive predictive value (PPV) 99%, negative predictive value (NPV) 89%. The patient-based analysis showed an AUC for fMRI of 0.975 (P < 0.001), a sensitivity of 98%, a specificity of 97%, a PPV of 98% and an NPV of 97%. Agreement on the PI-RADS score between both protocols was found to be good (κ = 0.78 [0.57; 0.99]); fMRI missing PI-RADS 4 lesions in three patients. Biopsy results showed no cancer in two patients (two cores per nodule) and Gleason 6 cancer in one patient. There was only one false-positive fMRI, with a PI-RADS score of 4, whose biopsy was negative. CONCLUSION: In the triage of men with a high risk of PCa for prostate biopsy, an f MRI protocol (1.5-T magnet, T2WI + DWI, <15 min) may safely replace the traditional ESUR 3.0-T mpMRI protocol, saving time and contrast injection.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Van Nieuwenhove S, Saussez TP, Thiry S, et al. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer. BJU Int. 2018. PMID: 30240059. doi:10.1111/bju.14538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。